Summit Therapeutics
SMMT
SMMT
211 hedge funds and large institutions have $1.89B invested in Summit Therapeutics in 2025 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 77 increasing their positions, 69 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
211
Holders Change
+8
Holders Change %
+3.94%
% of All Funds
2.87%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.04%
New
43
Increased
77
Reduced
69
Closed
34
Calls
$45.5M
Puts
$65.7M
Net Calls
-$20.2M
Net Calls Change
-$2.98M
Top Buyers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$25.4M |
| 2 |
Pictet Asset Management
Carouge,
Switzerland
|
+$25M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.7M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$13.4M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$22.4M |
| 2 |
State Street
Boston,
Massachusetts
|
-$14.5M |
| 3 |
Goldman Sachs
New York
|
-$6.5M |
| 4 |
BCM
Boxer Capital Management
San Diego,
California
|
-$4.46M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$3.99M |
